Better Risk Assessment for Individual Substances

Neuroscience

• Hypertension 100%
• Monoamine Oxidase Inhibitor 100%
• Tricyclic Antidepressant 66%
• Analeptic 33%
• Antidepressant 33%
• Differential Diagnosis 33%
• Risperidone 33%
• Bupropion 33%
• Duloxetine 33%
• Desipramine 33%
• Moclobemide 33%
• Venlafaxine 33%
• Tyramine 33%
• Clozapine 33%
• Quetiapine 33%
• Tranylcypromine 33%
• Reboxetine 33%
• Rasagiline 33%
• Milnacipran 33%
• Modafinil 33%
• Atomoxetine 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Tricyclic Antidepressant 66%
• Quetiapine 33%
• Tranylcypromine 33%
• Milnacipran 33%
• Rasagiline 33%
• Desipramine 33%
• Atomoxetine 33%
• Reboxetine 33%
• Moclobemide 33%
• Venlafaxine 33%
• Risperidone 33%
• Modafinil 33%
• Dexamphetamine 33%
• Clozapine 33%
• Orthostatic Intolerance 33%
• Orthostatic Hypotension 33%
• Hypertensive Crisis 33%
• Hypotension 33%
• Duloxetine 33%
• Bupropion 33%

Medicine and Dentistry

• Blood Pressure 100%
• Monoamine Oxidase Inhibitor 60%
• Differential Diagnosis 20%
• Hypertension 20%
• Hypotension 20%
• Duloxetine 20%
• Bupropion 20%
• Neuroleptics 20%
• Dextroamphetamine 20%
• Diet Restriction 20%
• Hypertensive Crisis 20%
• Tranylcypromine 20%
• Venlafaxine 20%
• Clozapine 20%
• Milnacipran 20%
• Atomoxetine 20%
• Reboxetine 20%